688189 Hunan Nucien Pharmaceutical Co., Ltd.
- 5.74
- -0.02-0.35%
Hunan Nucien Pharmaceutical Co., Ltd. News
Announcement on the progress of repurchasing the company's shares through centralized bidding trade.
Announcement on the use of some overraised funds to permanently replenish working capital
Western Securities Co., Ltd.'s verification opinion on the company's use of part of the overfunded capital to permanently supplement working capital
Independent opinions of independent directors on matters relating to the 10th meeting of the second board of directors of the company
Announcement on holding the results briefing for the first quarter of 2023 and 2024
Notice on convening the 2023 Annual General Meeting of Shareholders
2023 Independent Director Debriefing Report (Ding Fangfei)
2023 Independent Director Debriefing Report (Han Yu Ming)
2023 Independent Director Debriefing Report (Kang Cailian)
2023 Independent Director's Debriefing Report (Nie Ruqiong)
2023 Independent Director Debriefing Report (Shen Yunqiao)
2023 Independent Director Debriefing Report (Zhang Da)
2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Resolutions of the Eighth Meeting of the Second Board of Supervisors
Announcement on the progress of shareholders' holdings of 5% or more who have reduced their holdings by more than half of the time and have not reduced their holdings
Notice on Response to the 2023 Annual Report Information Disclosure Regulatory Inquiry Letter
Special instructions on financial matters in the information disclosure inquiry letter of Dahua Certified Public Accountants on the Company's 2023 Annual Report
Announcement on the progress of the repurchase of company shares through centralized bidding transactions
Nanxin Pharmaceutical 2024 First Quarter Report
Nanxin Pharmaceutical's 2024 “Improve Quality, Increase Efficiency, and Value Rewards” Action Plan
Analysis
Price Target
No Data
